Tyler Golato

Molecule AG is a collaborative platform that connects stakeholders in drug development to accelerate the process of bringing novel therapeutics to patients. Molecule AG is based in Neuhausen am Rheinfall, Switzerland and was founded by Paul Kohlhaas, Tyler Golato, and Titian Steiger, with Paul Kohlhaas serving as the CEO since incorporation. The Swiss company turns intellectual property and its development into a liquid and easily investable asset, connecting leading researchers to investment opportunities.

VitaDAO is a community-owned collective that funds and commercializes longevity therapeutics. VitaDAO is a decentralized drug development organization that supports academic projects and funds translational R&D projects with a view to commercialization of the resulting IP. The American company offers one year of support for up to $250,000 in exchange for the resulting IP. VitaDAO is an active and diverse community of contributors who can apply for a working group and become a contributor to earn $VITA. The company is interested in longevity research and provides funding and support for researchers, technologists, and funding partners from application to project funding and beyond. The company was founded in 2021 by Laurence Ion, Vincent Weisser, Alex Dobrin, Tim Peterson, Tyler Golato, Paul Kohlhaas.